chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Bruise at the site of injection; Heart rate increased from 60 to 113; Felt like a mac truck run over her; Muscle ache; Fatigue; Low graded fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (Bruise at the site of injection), HEART RATE INCREASED (Heart rate increased from 60 to 113), FEELING ABNORMAL (Felt like a mac truck run over her), MYALGIA (Muscle ache) and FATIGUE (Fatigue) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced VACCINATION SITE BRUISING (Bruise at the site of injection), HEART RATE INCREASED (Heart rate increased from 60 to 113), FEELING ABNORMAL (Felt like a mac truck run over her), MYALGIA (Muscle ache), FATIGUE (Fatigue), PYREXIA (Low graded fever) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE BRUISING (Bruise at the site of injection) had not resolved and HEART RATE INCREASED (Heart rate increased from 60 to 113), FEELING ABNORMAL (Felt like a mac truck run over her), MYALGIA (Muscle ache), FATIGUE (Fatigue), PYREXIA (Low graded fever) and CHILLS (Chills) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. Treatment for the events included acetaminophen.   This case was linked to MODERNATX, INC.-MOD-2021-038174 (E2B Linked Report).; Sender's Comments:  MODERNATX, INC.-MOD-2021-038174:wife case
A report has been received from a Health Professional concerning an 11 year old, Male subject, who had been receiving FLUMIST, (intranasal). FLUMIST started on an unknown date. It was reported that patient received half of a dose of FLUMIST in one nostril and other half squired into his face and maybe in his eye which started on 02-Nov-2013. The outcome of the event of received half of a dose of FLUMIST in one nostril and other half squirted into his face and maybe eye is unknown. The report was considered to be non-serious.
Mild headache and brain for for 24 hours after the shot. Itchy rash at injection site developed 7 days after receiving shot. The rash feels hot both to the touch and within the muscle.
Headache, diffuse body aches, fatigue, malaise, nausea, difficulty sleeping, low grade fevers, chills.  Right arm where vaccine administered painful, swollen and firm.  He has had difficulty moving his right hand.
pt recv vax 4NOV98 & 5NOV98 mom noticed some redness of rt arm near inj site;later that day father noticed swelling & redness;pt seen @ urgent care & dx w/cellulitis;started on ATB for 7-10 day course-pt fine according to mom 3 days later;
About 2 weeks after shot (dose 2) had lower back pain and inflammation/tightness around knees.  Felt loss of strength and flexibility.  Had much longer exercise recovery time than usual.  Was even hard to put feet up on foot stool without pain.  Had to keep moving to stay comfortable.  No redness.  Upper body and hips were not affected.  This lasted 6 weeks.   Was "drastic change in health."  Would have to pause before walking after standing up due to pain.  Advil helped some.  It gradually improved over time.  Did not resume running until late August and had to work back up to it.
Difficulty breathing, legs hurt and very hard to lift them to move, paralysis, scab-like sore on side of mouth, dark circles under eyes, fever of 101.3, lethargic.
Numbness began on the left side of my foot.  Then spread to right foot.  Now numbness/tingling in both hands and spreading up the legs.
On 7/5/01 at 15:00, I received a phone call from patientl's wife, who is also an employee there. She told me that a "Neurologist, told us it was the Hep vaccine that caused the seizures. She told me to notify you that you should call the number on the bottom of the paper (drug insert) to report it." Most of my information has come from the wifel, not from the patient or the physician. Consequently, I am unable to verify actual events, facts, etc. I do hope that the following information that I am furnishing will be of assistance to you.
This spontaneous report was received from a female patient of unknown age regarding herself. The patient's pertinent medical history was not reported. On an unknown date, the patient was vaccinated with RECOMBIVAX HB (dose, frequency and route were not reported). On an unknown date, blood work showed negative for hepatitis B antibodies and now on an unknown date, her blood work showed a "false positive" for hepatitis B antibodies the patient experienced hepatitis B surface antibody negative. The outcome of the event was unknown. The causality of the event was not reported. Additional information is not expected as contact details were not reported.
Information has been received from a physician concerning a 29 year old female, for the Pregnancy Registry for GARDASIL, who on approximately 03-NOV-2009, "between week 4 and 5 of the patient's pregnancy", was vaccinated with a dose of GARDASIL (Lot No. not reported). It was reported that on 15-JUL-2010, 40 weeks from LMP, the patient delivered a female baby with 7 pounds and 1 ounces of weight, apgar score 8/9. Additional information has been received from the patient. She stated that her baby was doing well, but the pediatrician was following the baby's hemangioma on her neck (from birth), and an MRI of the fontanel was scheduled for next week. The mother's experience was captured in WAES# 0912USA01998. Additional information has been requested.
The back of right leg is extremely tight only on the backside; The back of right leg is extremely tight only on the backside and has a burning sensation. The lower back side is have the same sensation.; It is progressing with all of these sensations, very strange.; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO181) via an unspecified route of administration in the left arm on 25Jun2021 at 15:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included services (as reported). Prior to the vaccination, the patient was not diagnosed with COVID-19. On 01Dec2020, the patient underwent Covid-19 test via nasal swab and the result found to be negative. The patient did not receive other vaccines within 4 weeks prior to the vaccination. Concomitant medications included felbamate (MANUFACTURER UNKNOWN); lamotrigine (MANUFACTURER UNKNOWN) and atorvastatin (MANUFACTURER UNKNOWN), all taken for an unknown indication from an unknown date and unknown if ongoing. The patient previously received morphine (MANUFACTURER UNKNOWN) and experienced drug allergy. On 26Jun2021 at 04:00, the patient experienced that the back of her right leg was extremely tight only on the backside and had a burning sensation. The lower back side was having the same sensation. It was progressing with all of these sensations, very strange. The events did not result in a visit to the doctors or other healthcare professional office/clinic, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events the back of right leg was extremely tight, only on the backside and had a burning sensation, the lower back side was having the same sensation, progressing with all of these sensations, very strange was not resolved at the time of this report.
pt recv vax 21JAN97 & it was reported that CBC count taken on 27JAN97 indicated neutropenia & 3FEB97 a second test indicated 0% segmented & 3% non-segmented neutrophils;RBC & platelets were nl;
This spontaneous report as received on 02-MAR-2017 from a female healthcare worker (Not further specified if a healthcare professional), refers to 10 patients (age and gender not reported) who received unspecified doses in VARIVAX (Lot number M033905, expiration date 20-JUL-2018) immunization series that were improperly stored. The site and route of VARIVAX administration were not reported. The vaccinations occurred between 22-FEB-2017 and 01-MAR-2017. The vaccines were exposed to temperature of 18.5F (Fahrenheit) for a time frame of 5.3 hours. There were no previous temperature excursions reported. The temperature excursion was recorded by a data logger. The patients' pertinent medical history, concomitant medications and drug allergies were not reported. It was further specified that on 28-FEB-2017, this patient (age and gender not reported) received administration of VARIVAX. No adverse effects were reported. There was no product quality complaint involved. No further information was provided. This is one of the several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1703USA001788.
02/18/2003- Anthrax (2), given in left arm: Local: Experienced local reaction similar to that following first anthrax vaccine ( minimal redness, swelling and tenderness surrounding vaccine site for  (approximately 2-3 days). Also, developed pruritic knot at vaccine site which did not resolve before the next anthrax vaccine was given in her left arm. Systemic: Does not recall experiencing chills, headaches, muscle aches, or joint pain following vaccine. Within the first week of vaccine receipt, experienced onset of mild fever, significant fatigue and swollen glands in her neck. The fatigue has persisted, and the mild fevers with lymphadenopathy have recurred intermittently.
flulike symptoms:  general malaise, body aches, low grade fever,  pain at site of injection symptoms began appx. 12 hours after injection and continued for the next 24 hours
Vaccine had been inadvertently stored at freezer temperatures (-5 to 0 degrees Fahrenheit), rather than at recommended refrigerator temperatures since it's arrival at our facility on 8/12/2022.
No adverse event reported. 7 mo old was given KINRIX (DTAP/IPV) inadvertently. Advised by manufacturer to report to VAERS in the event child ever had reaction after this date.
COMPLAIN OF REDNESS, WARMTH, AND SWELLING TO RIGHT ARM 1 DAY AFTER RECEIVING VACCINES. REDNESS COMPLETELY AROUND ARM FROM SHOULDER TO ELBOW. IN DOCTOR'S OFFICE, RIGHT ARM WAS 4CM BIGGER THAN LEFT ARM.
Dizziness, NauseaVomiting, NAUSEA. FEELING LIGHT HEADED AND ABOUT TO FAINT
2 dose of moderna I experienced the worst ear ache; This spontaneous case was reported by a patient and describes the occurrence of EAR PAIN (2 dose of moderna I experienced the worst ear ache) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EAR PAIN (2 dose of moderna I experienced the worst ear ache). At the time of the report, EAR PAIN (2 dose of moderna I experienced the worst ear ache) had not resolved. No concomitant medications were reported. Patient received 2 dose of moderna and experienced the worst ear ache ever. Since then patient saw her ear Dr. Patient have same constant ear ache. It goes on for hours and days. No treatment medications were reported. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
The event actually occurred at the mixing of the vaccine  Pfizer vaccine was diluted with 1.8ml of Moderna vaccine instead of sodium chloride vaccine  patient due in November
Myalgia, Arthralgia, Developed LBP, myalgias, and arm soreness after 2nd  Moderna COVID Vaccine Narrative:  Developed LBP, myalgias, and arm soreness after 2nd Moderna COVID Vaccine causing one day off work.  Other Relevant History:
This spontaneous report was received from a other health professional referring to a patient of unknown age and gender. Medical history and current conditions were not reported. On 10-MAR-2016, the patient was orally vaccinated with improperly stored dose of ROTATEQ (dose, frequency and indication were not reported; lot # L037924 with expiration date: 22-JUN-2017). Concomitant therapy was not reported. No adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous report as received from a healthcare worker refers to a 4 years old patient. On 31-MAR-2014 the patient, was vaccinated with M-M-R II lot # 0234AE, 0.5 ml, subcutaneous. No concomitant medication or medical history was reported. The health care worker informed that on 31-MAR-2014 the patient received expired dose of M-M-R II expire date 26-JAN-2014. No adverse event effect was reported. Additional information has been requested.
Moderna COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccines on 02/06/21 and 03/04/2021. COVID-19 + at outside facility 1/6/22. COVID-19 + 1/13/22. Presented to ED on 1/21/22 for 10 days of COVID-19 symptoms including progressive fatigue and SOB. Admitted for acute hypoxemic respiratory failure due to Covid-19 PNA.. In ED had O2 sat of 93% at rest but 86% after exertion and was placed on 2L O2. Found to have AKI w/ Cr >2 and was given 2L of fluids. Treated with dexamethasone. Continued to deteriorate, status changed to DNAR/COT. Expired 1/25/22.
tested positive for COVID-19 after receiving the vaccine; Fever 100.-100.3; Body Aches; Chills; Full blown head cold; Nasal Congestion; Very Weak; Worst Headache; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Full blown head cold), NASAL CONGESTION (Nasal Congestion), ASTHENIA (Very Weak), COVID-19 (tested positive for COVID-19 after receiving the vaccine) and HEADACHE (Worst Headache) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included MS (She has mild MS).    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced HEADACHE (Worst Headache). On 14-Feb-2021, the patient experienced NASOPHARYNGITIS (Full blown head cold), NASAL CONGESTION (Nasal Congestion), ASTHENIA (Very Weak), MYALGIA (Body Aches) and CHILLS (Chills). On 18-Feb-2021, the patient experienced PYREXIA (Fever 100.-100.3). On an unknown date, the patient experienced COVID-19 (tested positive for COVID-19 after receiving the vaccine). At the time of the report, NASOPHARYNGITIS (Full blown head cold), NASAL CONGESTION (Nasal Congestion), ASTHENIA (Very Weak), COVID-19 (tested positive for COVID-19 after receiving the vaccine), HEADACHE (Worst Headache), MYALGIA (Body Aches), CHILLS (Chills) and PYREXIA (Fever 100.-100.3) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Feb-2021, Body temperature: 100-100.3 °f (High) 100-100.3 °F. In 2021, SARS-CoV-2 test: positive (Positive) Covid positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitantly patient was taking unspecified mediation for MS (multiple sclerosis). The patient is unsure if COVID-19 is a side effect of the vaccine or if she contracted the virus at the facility where she went to receive the vaccine. Treatment information was not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: TCR: Patient tested positive for COVID-19 after receiving the vaccine
Fever - 100.6. Breath holding spell -> lead to a brief unconscious period lasting 3 min. No tremors.
Woke up next day feeling ill with pains in my arm from elbow to shoulder also in ankles. Feel very ill and still do, 3 wks later. getting physical therapy for pains.
sore arm; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication included oral medication for diabetes No treatment information provided   This case was linked to MOD-2021-014421, MOD-2021-014394 (Linked Report).; Sender's Comments:  MOD-2021-014421:Same reporter, different patient MOD-2021-014394:Same reporter, different patient
Other severe and personal injuries which are permanent and lasting in nature; Shingles including any and all of its sequelae; This initial spontaneous report was received from a lawyer and a 76 year old female patient regarding a case in litigation on 24-MAR-2020. Her Medical history, concurrent conditions, concomitant medication, drug reactions or allergies were not provided. On an unspecified date in 2012, the patient was vaccinated with a dose of zoster vaccine live (ZOSTAVAX) (dose, lot number, expiration date, route of administration, and anatomical location not provided) as prophylaxis. As a result of her receipt of zoster vaccine live (ZOSTAVAX), in 2012, the patient suffered shingles, including any and all of its sequelae. As a result, patient had been caused to suffer severe personal injuries, pain, suffering, and emotional distress, as well as to incur substantial economic damages. Also, the patient was caused to suffer other severe and personal injuries (unspecified), which were permanent and lasting in nature, physical pain and mental anguish, including diminished enjoyment of life, as well as the need for lifelong medical treatment, monitoring and/or medications. The patient required and/or would require more health care and services and did incur medical, health, incidental and related expenses. The patient was informed and believed and further alleged that would in the future be required to obtain further medical and/or hospice care, attention, and services. At the reporting time, the outcome of shingles and the other unspecified permanent injuries was considered as not recovered. The reporters considered the events to be related to zoster vaccine live (ZOSTAVAX).   The reporters considered the other severe and permanent injuries (unspecified) event to be disabling.
Crying - inconsolable after imms. 05-30-17. No further complaints over last 2 days.
Hot flashes; Insomnia; Mild headache; Weakness; Chills; Fatigue; Muscle pain; Sore arm; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the right arm on an unknown date in Apr2021 at 10:45 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the right arm on an unknown date in Mar2021 at 10:30 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. On an unknown date in Apr2021 at 12:00, the patient experienced mild headache, chills, hot flashes, fatigue, weakness, muscle pain, sore arm and insomnia. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were not taken as a result of reported events. The clinical outcome of the mild headache, chills, hot flashes, fatigue, weakness, muscle pain, sore arm and insomnia was recovered on unknown date in Apr2021.  No follow-up attempts are possible. No further information is expected.
lymph nodes are swollen on left side; soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (lymph nodes are swollen on left side) and VACCINATION SITE PAIN (soreness at the injection site) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 034F21A, 002B21A and 015M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Nov-2021, the patient experienced LYMPHADENOPATHY (lymph nodes are swollen on left side). 11-Nov-2021, the patient experienced VACCINATION SITE PAIN (soreness at the injection site). At the time of the report, LYMPHADENOPATHY (lymph nodes are swollen on left side) and VACCINATION SITE PAIN (soreness at the injection site) outcome was unknown.            No concomitant products were reported. No treatment information was reported by the reporter.   This case was linked to MOD-2021-385895 (Patient Link).
reconstituted with a unapproved diluent; administrated a dose of Menveo reconstituted with a unaproved diluent.; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate dose of vaccine administered in a 11-year-old female patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis.   On 10th November 2021, the patient received Menveo. On 10th November 2021, unknown after receiving Menveo, the patient experienced inappropriate dose of vaccine administered and wrong solution used in drug reconstitution. On an unknown date, the outcome of the inappropriate dose of vaccine administered and wrong solution used in drug reconstitution were unknown.  Additional details were reported as follows: Health care professional (HCP) report that on the same day of the reporting a patient was administrated a dose of Menveo reconstituted with a unaproved diluent, which led to inappropriate dose of vaccine administered and wrong solution used in drug reconstitution.  No further events were reported.  The reporter agreed to be contacted for follow up.
Seen at Greenwich hospital due to swelling LL Noted to be warm to area, a febrile, some erythema persists on exam 8/11 but generally improved. Advised to use Tylenol supp for temp.
Within 5 minutes I became very light headed and weak.  Also very hot and shaky. They had to put me into another room that was much cooler and put me into a recliner with feet up, ice behind my neck and on my forehead. I was pushing water so it was not dehydration, and I had eaten my normal healty breakfast also so not low blood sugar. This was my second shot and I had the same reaction with the first shot. It took about an hour before I could stand and walk again, but was still a bit shaky and faintly light headed for about another hour.